The cluster is small in dollar terms relative to the $962M market cap and dominated by asset managers rather than activist or event-driven funds. The mixed signals and lack of insider buying suggest no strong shared thesis. Monitor the strategic alternatives review outcome for a potential catalyst.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $10.61entry
- T+1 · 8d ago +3.82%α +1.45% · $11.02
- T+5 · 4d ago +0.47%α −2.12% · $10.66
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Four institutional investors added to Bioventus positions in Q3 2026, totaling $1.8M in net buying, while three trimmed or nearly exited, reducing holdings by $1.3M. The cluster shows mixed conviction with a slight accumulation bias, but the 45-day reporting lag means these positions may already be stale. The moves follow Q3 earnings that slightly missed revenue consensus and a narrowed full-year guidance range.
Key Financial Metrics
Institutional Positions
Net institutional flow: $500.0K
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Bank Of New York Mellon | ADD | +28% | $2.7M | $1.2M |
| Strs Ohio | ADD | +55.3% | $620.0K | $344.0K |
| Creative Planning | ADD | +83.7% | $344.0K | $214.0K |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Fifth Third Bancorp | TRIM | -74.6% | $1.5M | -$927.0K |
| Citigroup | NEAR_EXIT | -93.1% | $365.0K | -$329.0K |
| Barclays | TRIM | -31% | $517.0K | -$2.0K |
Key Facts
- 4 buyers added $1.8M in net new value, 3 sellers reduced by $1.3M
- Largest buyer: Bank Of New York Mellon added $1.2M (+28% shares)
- Largest seller: Fifth Third Bancorp trimmed $927K (-74.6% shares)
- No open-market insider buying in the same window (confluence score 25/100)
- Q3 2026 revenue of $142.4M missed consensus of $149.5M; full-year guidance narrowed to $590M-$595M
Financial Impact
Net institutional accumulation of $0.5M across 7 filers; total buying value $1.8M vs selling value $1.3M
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- Revenue miss and guidance cut in Q3 earnings could weigh on near-term sentiment
- No insider buying to corroborate institutional accumulation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BVS-2026-Q3 |
Track record
18 reports on BVS
2 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +37.19% at T+60 after the May 8, 2026 report. 3 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $10.66 settles Feb 11
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Viewing Entry $10.61 settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 5/10 No price data
- Nov 2, 202614d ago Press Release Neutral 5/10 Entry $10.95 settles Feb 1
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $14.65 settles Jan 26
- Aug 15, 202613w ago Institutional Cluster Mixed 5/10 Entry $13.88 to $11.02 ▼ −20.64% −17.88% vs SPY
- Aug 5, 202614w ago 8-K Bullish 7/10 No price data
- Aug 5, 202614w ago Press Release Bullish 7/10 Entry $15.26 to $14.86 ▼ −2.62% −2.81% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 4/10 Entry $8.68 to $14.07 ▼ −62.10% −57.70% vs SPY
- Jun 2, 202623w ago Press Release Bearish 6/10 Entry $8.11 to $13.97 ▼ −72.26% −71.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers